100 Questions & Answers About Ovarian Cancer | Agenda Bookshop Skip to content
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
A01=Don S. Dizon
A01=Nadeem R. Abu-Rustum
Age Group_Uncategorized
Age Group_Uncategorized
Author_Don S. Dizon
Author_Nadeem R. Abu-Rustum
automatic-update
Category1=Non-Fiction
Category=MJCL
Category=MJT
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Not available (reason unspecified)
Price_€10 to €20
PS=Active
softlaunch

100 Questions & Answers About Ovarian Cancer

English

By (author): Don S. Dizon Nadeem R. Abu-Rustum

Whether youre a newly diagnosed ovarian cancer patient, a survivor, or a friend or relative of either, this book offers help. Completely updated, the new third edition of 100 Questions & Answers About Ovarian Cancer gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a gynecologic oncologist and a gynecologic surgeon, with actual patient commentary, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease. See more
Current price €18.99
Original price €19.99
Save 5%
A01=Don S. DizonA01=Nadeem R. Abu-RustumAge Group_UncategorizedAuthor_Don S. DizonAuthor_Nadeem R. Abu-Rustumautomatic-updateCategory1=Non-FictionCategory=MJCLCategory=MJTCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=Not available (reason unspecified)Price_€10 to €20PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 227g
  • Publication Date: 17 Sep 2015
  • Publisher: Jones and Bartlett Publishers Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781284090284

About Don S. DizonNadeem R. Abu-Rustum

Don S. Dizon is a Professor of Medicine at Brown University. He is a medical oncologist specializing in breast and pelvic malignancies survivorship (particularly as it pertains to sexual health for men and women with cancer) patient engagement and social media. He grew up on the Pacific Island of Guam and completed undergraduate and medical school at the University of Rochester in New York. He trained in Internal Medicine at Yale New-Haven Hospital and completed a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in NYC. He serves as the Director of Womens Cancers and Director of Hematology-Oncology clinics at Lifespan Cancer Institute and Director of Medical Oncology at Rhode Island Hospital. Additionally he leads Community Outreach and Engagement for The Cancer Center at Brown University and serves as Chair of Digital Engagement for SWOG Oncology Research Network and Co-Chief Medical Officer of the Global Cancer Institute. He writes an online column for the journal The Oncologist and for ASCO Connection. Dr. Dizon is a founding member of the Collaboration for Outcomes Using Social Media in Oncology and is active on many platforms including Twitter Instagram Facebook and TikTok. Follow him @drdonsdizon. Nadeem R. Abu-Rustum M.D. is Associate Attending and Director of Minimally Invasive Surgery and Resident and Medical Student Education Gynecology Service Department of Surgery at Memorial Sloan-Kettering Cancer Center in New York. He completed his Internship and Residency in Obstetrics and Gynecology at the Greater Baltimore Medical Center in Baltimore Maryland and a Fellowship in Gynecologic Oncology at Memorial Sloan-Kettering Cancer Center in New York He is in full-time practice of gynecologic oncology and his clinical research interest is in gynecologic cancer surgery including surgery for ovarian uterine and cervical cancers.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept